Literature DB >> 17053832

TLR4 links innate immunity and fatty acid-induced insulin resistance.

Hang Shi1, Maia V Kokoeva, Karen Inouye, Iphigenia Tzameli, Huali Yin, Jeffrey S Flier.   

Abstract

TLR4 is the receptor for LPS and plays a critical role in innate immunity. Stimulation of TLR4 activates proinflammatory pathways and induces cytokine expression in a variety of cell types. Inflammatory pathways are activated in tissues of obese animals and humans and play an important role in obesity-associated insulin resistance. Here we show that nutritional fatty acids, whose circulating levels are often increased in obesity, activate TLR4 signaling in adipocytes and macrophages and that the capacity of fatty acids to induce inflammatory signaling in adipose cells or tissue and macrophages is blunted in the absence of TLR4. Moreover, mice lacking TLR4 are substantially protected from the ability of systemic lipid infusion to (a) suppress insulin signaling in muscle and (b) reduce insulin-mediated changes in systemic glucose metabolism. Finally, female C57BL/6 mice lacking TLR4 have increased obesity but are partially protected against high fat diet-induced insulin resistance, possibly due to reduced inflammatory gene expression in liver and fat. Taken together, these data suggest that TLR4 is a molecular link among nutrition, lipids, and inflammation and that the innate immune system participates in the regulation of energy balance and insulin resistance in response to changes in the nutritional environment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17053832      PMCID: PMC1616196          DOI: 10.1172/JCI28898

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

Review 1.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Role of the sulfonylurea receptor in regulating human adipocyte metabolism.

Authors:  H Shi; N Moustaid-Moussa; W O Wilkison; M B Zemel
Journal:  FASEB J       Date:  1999-10       Impact factor: 5.191

3.  The hormone resistin links obesity to diabetes.

Authors:  C M Steppan; S T Bailey; S Bhat; E J Brown; R R Banerjee; C M Wright; H R Patel; R S Ahima; M A Lazar
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

4.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.

Authors:  K Hoshino; O Takeuchi; T Kawai; H Sanjo; T Ogawa; Y Takeda; K Takeda; S Akira
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

Review 5.  Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways.

Authors:  D Hwang
Journal:  FASEB J       Date:  2001-12       Impact factor: 5.191

6.  Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components.

Authors:  N Laflamme; S Rivest
Journal:  FASEB J       Date:  2001-01       Impact factor: 5.191

7.  Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells.

Authors:  Harald Staiger; Katrin Staiger; Norbert Stefan; Hans Günther Wahl; Fausto Machicao; Monika Kellerer; Hans-Ulrich Häring
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

8.  Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function.

Authors:  K T Uysal; S M Wiesbrock; M W Marino; G S Hotamisligil
Journal:  Nature       Date:  1997-10-09       Impact factor: 49.962

9.  Lipopolysaccharide stimulates nitric oxide synthase-2 expression in murine skeletal muscle and C(2)C(12) myoblasts via Toll-like receptor-4 and c-Jun NH(2)-terminal kinase pathways.

Authors:  Robert A Frost; Gerald J Nystrom; Charles H Lang
Journal:  Am J Physiol Cell Physiol       Date:  2004-07-28       Impact factor: 4.249

10.  Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity.

Authors:  A Dresner; D Laurent; M Marcucci; M E Griffin; S Dufour; G W Cline; L A Slezak; D K Andersen; R S Hundal; D L Rothman; K F Petersen; G I Shulman
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

View more
  1312 in total

Review 1.  cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance.

Authors:  Guadalupe Sabio; Roger J Davis
Journal:  Trends Biochem Sci       Date:  2010-05-07       Impact factor: 13.807

2.  Targeted deletion of endothelial lipase increases HDL particles with anti-inflammatory properties both in vitro and in vivo.

Authors:  Tetsuya Hara; Tatsuro Ishida; Yoko Kojima; Hanayo Tanaka; Tomoyuki Yasuda; Masakazu Shinohara; Ryuji Toh; Ken-ichi Hirata
Journal:  J Lipid Res       Date:  2010-10-06       Impact factor: 5.922

3.  Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands.

Authors:  Xiaoxia Z West; Nikolay L Malinin; Alona A Merkulova; Mira Tischenko; Bethany A Kerr; Ernest C Borden; Eugene A Podrez; Robert G Salomon; Tatiana V Byzova
Journal:  Nature       Date:  2010-10-03       Impact factor: 49.962

Review 4.  Inflammatory links between obesity and metabolic disease.

Authors:  Carey N Lumeng; Alan R Saltiel
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

Review 5.  Adipose tissue remodeling and obesity.

Authors:  Kai Sun; Christine M Kusminski; Philipp E Scherer
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

Review 6.  Immunomodulation at epithelial sites by obesity and metabolic disease.

Authors:  Kitty P Cheung; Kristen R Taylor; Julie M Jameson
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

Review 7.  Neuroinflammatory basis of metabolic syndrome.

Authors:  Sudarshana Purkayastha; Dongsheng Cai
Journal:  Mol Metab       Date:  2013-10-05       Impact factor: 7.422

8.  Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity.

Authors:  Nicole H Rogers; James W Perfield; Katherine J Strissel; Martin S Obin; Andrew S Greenberg
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

9.  Pyroglutamylated RF-amide peptide (QRFP) gene is regulated by metabolic endotoxemia.

Authors:  Christian Jossart; Mukandila Mulumba; Riccarda Granata; Davide Gallo; Ezio Ghigo; Sylvie Marleau; Marc J Servant; Huy Ong
Journal:  Mol Endocrinol       Date:  2013-01-01

10.  Alterations of Cholesterol Metabolism in Inflammation-Induced Atherogenesis.

Authors:  David P Hajjar; Katherine A Hajjar
Journal:  J Enzymol Metab       Date:  2016-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.